Endocrine oncology

A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations

J Clin Endocrinol MetabPublished Mechanistic study

Authors' conclusion

Biallelic inactivation of CDC73 is essential for parathyroid tumorigenesis in carriers harboring germline mutations of this gene. Despite sharing some genomic features with adenomas, parathyroid carcinomas have more distinctive alterations in the genome, some of which may be critical for cancer formation.

Study context

Population
Parathyroid tumors harboring germline CDC73 mutations and their matched normal tissues
Participants
12 parathyroid tumors
Comparison
Parathyroid carcinomas vs adenomas harboring germline CDC73 mutations
  • Carcinomasn = 6
  • Adenomasn = 6reference
Outcome
Second CDC73 allele status and genomic landscapes
Methodological detailswhole-exome and RNA sequencing, matched normal tissues
  • Whole-exome and RNA sequencing
  • Matched normal tissues

Main finding

As reported in the abstract

Tumors with 1 somatic event predicted to completely inactivate the second CDC73 allele

All 12

Original publication

A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. J Clin Endocrinol Metab. Published 24 July 2024. doi:10.1210/clinem/dgae506

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.